Analyst Reco. Bio-Techne Corporation

Equities

TECH

US09073M1045

Market Closed - Nasdaq Other stock markets 01:30:00 02/05/2024 am IST			5-day change	1st Jan Change
73.46 ^USD	+16.22%		+15.65%	-4.80%

01/05	Equity Markets Mostly Fall After Fed Leaves Rate Unchanged	MT
01/05	Equity Markets Mostly Fall After Fed Leaves Rate Unchanged	MT

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Deutsche Bank Adjusts Price Target on Bio-Techne to $84 From $82	01/05	MT
RBC Capital Adjusts Price Target on Bio-Techne to $71 From $79	29/04	MT
Deutsche Bank Adjusts Bio-Techne Price Target to $82 From $85	18/04	MT
RBC Raises Price Target on Bio-Techne to $79 From $75, Keeps Sector Perform Rating	08/04	MT
Stephens Adjusts Bio-Techne's Price Target to $87 From $70, Keeps Overweight Rating	03/02	MT
Deutsche Bank Cuts Bio-Techne Price Target to $85 From $88, Maintains Buy Rating	02/02	MT
RBC Cuts Price Target on Bio-Techne to $75 From $85, Notes Revenue Growth Turned Negative, Keeps Sector Perform Rating	02/02	MT
Stifel Nicolaus Downgrades Bio-Techne to Hold from Buy, $65 Price Target	02/02	MT
UBS Initiates Coverage on Bio-Techne With Buy Rating, $80 Price Target	07/12	MT
Deutsche Bank Cuts Bio-Techne Price Target to $70 From $100, Maintains Buy Rating	01/11	MT
KeyBanc Cuts Price Target on Bio-Techne to $80 From $115, Maintains Overweight Rating	01/11	MT
RBC Trims Price Target on Bio-Techne to $83 From $85, Keeps Sector Perform Rating	01/11	MT
William Blair Initiates Coverage on Bio-Techne with Outperform Rating	28/23/28	MT
RBC Trims Bio-Techne's Price Target to $87 From $88, Keeps Sector Perform Rating	17/23/17	MT
RBC Trims Price Target on Bio-Techne to $88 From $90, Maintains Sector Perform Rating	15/23/15	MT
Baird Adjusts Price Target on Bio-Techne to $100 From $99, Maintains Outperform Rating	04/23/04	MT
RBC Lifts Price Target on Bio-Techne to $90 From $89 on View for Better 2024 EBITDA Margins, Keeps Sector Perform Rating	04/23/04	MT
RBC Lifts Price Target on Bio-Techne to $89 From $88, Maintains Sector Perform Rating	14/23/14	MT
RBC Lifts Price Target on Bio-Techne to $89 From $88, Maintains Sector Perform Rating	13/23/13	MT
RBC Trims Price Target on Bio-Techne to $88 From $89 After Fiscal Q2 Miss, Maintains Sector Perform Rating	06/23/06	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Analyst Reco. Bio-Techne Corporation

Equities

TECH

US09073M1045

Analyst Reco.

Filters